Skip to main content
Equibles

KMDA · Kamada Ltd · Metrics

Track KMDA — free

Use KMDA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KMDA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.05 -0.16 (-1.95%)
Rebalance outlook locked
Market Cap
$473.67M
Shares
57.69M

KMDA metrics

69 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.21
Market cap
$473.67M

Price action

20 metrics
Price change (1W)
-1.1%
Price change (30D)
+16.1%
Price change (3M)
+14.5%
Price change (6M)
-7.5%
Price change (YTD)
+17.4%
Price change (1Y)
+14.8%
Trailing year
Price change (5Y)
+55.0%
52-week high
$9.31
52-week low
$6.60
Change from 52-week high
-11.0%
Change from 52-week low
+25.6%
Annualized volatility
34.0%
Annualized volatility (3M)
30.3%
Beta
1.0
RSI (14D)
58.7
Price vs SMA 50
+10.1%
Price vs SMA 200
+5.8%
Avg volume (3M)
90,776
Relative volume
4.1
Average dollar volume
$702,602

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
57.69M

Valuation

12 metrics
P / E (TTM)
23.7
Trailing earnings · reciprocal yield 4.2%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.6×
reciprocal yield 38.1%
P / book
1.8
reciprocal yield 56.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
18.6
reciprocal yield 5.4%
Earnings yield
4.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
5.1%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.42
Dividend growth YoY
+110.0%
Dividend growth streak
—
Last ex-dividend
2026-08-27

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
42.3%
Operating margin
14.5%
Trailing 12 months
Net margin
—
Gross profit (TTM)
$76.41M
Operating profit (TTM)
$26.23M
Net income (TTM)
$20.44M
Trailing 12 months
Diluted EPS (TTM)
$0.35
FCF margin
—
Effective tax rate
13.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$4.66

Growth

11 metrics
Revenue growth YoY
+14.5%
Year over year
Net income growth YoY
+37.1%
Revenue (TTM)
$180.46M
Trailing 12 months
EPS growth YoY
+0.0%
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
+11.7%
Revenue CAGR (5Y)
+6.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-1.6%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
7.7%
Return on assets
5.4%
Debt / equity
—
Current ratio
4.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.3
Interest coverage
30.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$75.47M
Total assets
$378.71M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$25.49M
Capital expenditures (TTM)
—
R&D (TTM)
$12.99M
SG&A (TTM)
—
Stock compensation (TTM)
$845,000
R&D / revenue
7.2%
Stock compensation / revenue
0.5%

Ownership (13F)

3 metrics
13F filers
51
13F filer change QoQ
+8
Institutional ownership
8.6%

Short interest

3 metrics
Short interest
0.3%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1567529 CUSIP M6240T109 13F (30d) 35 filings 35 filers Visit website Investor relations